Oxidative stress in multiple sclerosis patients in clinical remission: Association with the expanded disability status scale

Journal of the Neurological Sciences

Volumn 321, Issue 1-2, 2012, Pages 49-53

  Oliveira, Sayonara Rangel ^a   Kallaur, Ana Paula ^a   Simão, Andréa Name Colado ^a   Morimoto, Helena Kaminami ^a   Lopes, Josiane ^a   Panis, Carolina ^b   Petenucci, Diego Lima ^a   Da Silva, Eloisa ^a   Cecchini, Rubens ^b   Kaimen Maciel, Damácio Ramon ^a   Reiche, Edna Maria Vissoci ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b Free Radical Physiopathology Laboratory   (Brazil)

Author keywords

Antioxidant; Carbonyl protein; EDSS; Lipid peroxidation; Multiple sclerosis; Oxidative stress

Indexed keywords

CARBONYL DERIVATIVE; HYDROPEROXIDE; NITRIC OXIDE; TERT BUTYL HYDROPEROXIDE; THIOL GROUP; URIC ACID;

ADULT; ARTICLE; BODY MASS; CHEMOLUMINESCENCE; CONTROLLED STUDY; DISEASE COURSE; ETHNICITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; GENDER; HUMAN; MALE; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; PARAMETERS; PRIORITY JOURNAL; PROTEIN CONTENT; REMISSION; SMOKING; TOTAL RADICAL TRAPPING ANTIOXIDANT PARAMETER; URIC ACID BLOOD LEVEL;

ADULT; DISABILITY EVALUATION; DISABLED PERSONS; FEMALE; HUMANS; LUMINESCENCE; MALE; MEDIATOR COMPLEX; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NITRIC OXIDE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; STATISTICS, NONPARAMETRIC; URIC ACID;

EID: 84866042186     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.07.045     Document Type: Article

References (32)

1. J. Witherick, A. Wilkins, N. Scolding, and K. Kemp Mechanisms of oxidative stress damage in multiple sclerosis and a cell therapy approach to treatment Autoimmune Dis 2011 2010 1 11
2. A.M. Amorini, A. Petzold, B. Tavazzi, J. Eikelenboom, G. Keir, and A. Belli Increased of uric acid and purine compounds in biological fluids of multiple sclerosis patients Clin Biochem 42 2009 1001 1006
3. C. Bjartmar, and B.D. Trapp Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences Curr Opin Neurol 14 2001 271 278
4. Y. Gilgun-Sherki, E. Melamed, and D. Offen The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy J Neurol 251 2004 261 268
5. L.M. Sayre, G. Perry, and M.A. Smith Oxidative stress and neurotoxicity Chem Res Toxicol 21 2008 172 188
6. G. Ferreti, T. Bacchetti, F. Principi, D.L. Ludovico, B. Viti, and V.A. Angeleri Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity Mult Scler 11 2005 677 682
7. E. Miller, M. Mrowicka, J. Saluk-Juszczak, and M. Ireneusz The level of isoprostanes as a non-invasive marker for in vivo lipid peroxidation in secondary progressive multiple sclerosis Neurochem Res 36 2011 1012 1016
8. M. Koch, J. Mostert, A.V. Arutjunyan, M. Stepanov, A. Teelken, and D. Heersema Plasma lipid peroxidation and progression of disability in multiple sclerosis Eur J Neurol 14 2007 529 533
9. E. Miller, A. Walczak, J. Saluk, M.B. Ponczek, and I. Majsterek Oxidative modification of patient's plasma proteins and its role in pathogenesis of multiple sclerosis Clin Biochem 45 2012 26 30
10. F. De Bustos, J.A. Navarro, C. De Andres, J.A. Molina, F.J. Jiménez-Jiménez, and M. Ortí-Pareja Cerebrospinal fluid nitrate levels in patients with multiple sclerosis Eur Neurol 41 1999 44 47
11. A.I. Danilov, M. Andersson, N. Bavand, N.P. Wiklund, T. Olsson, and L. Brundin Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis J Neuroimmunol 136 2003 112 118
12. N. Yuceyar, D. Taşkiran, and A. Saǧduyu Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients Clin Neurol Neurosurg 103 2001 206 211
13. J.P. Mostert, G.S.M. Ramsaransing, D.J. Heersema, M. Heerings, N. Wilczak, and J. De Keyser Serum uric levels and leukocyte nitric oxide production in multiple sclerosis patients outside relapses J Neurol Sci 231 2005 41 44
14. C.H. Polman, S.C. Reingold, G. Edan, M. Filippi, H.P. Hartung, and L. Kappos Diagnostic criteria for multiple sclerosis: revisions to the Mc-Donald Criteria Ann Neurol 58 2005 840 846
15. J.F. Kurtzke Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1983 1444 1452
16. C. Russo, F. Morabito, F. Luise, A. Piromalli, L. Battaglia, and A. Vinci Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis J Neurol 255 2008 64 69
17. B.G. Gonzales-Flecha, S. Llesuy, and A. Boveris Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver and muscle Free Radic Biol Med 10 1991 93 100
18. A.Z. Reznick, and L. Paccker Oxidative damage to proteins: spectrophotometric method for carbonyl assay Methods Enzymol 233 1994 357 363
19. C. Panis, A.C.S.A. Herrera, V.J. Victorino, F.C. Campos, L.F. Freitas, and T. de Rossi Oxidative stress and hematological profiles of advances breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy Breast Cancer Res Treat 133 2012 89 97
20. M.L. Hu Measurement of protein thiol groups and glutathione in plasma J.N. Abelson, M.I. Simon, Methods in Enzymology 1994 Academic Press California 380 382
21. M. Repetto, C. Reides, M.L. Gomez Carretero, M. Costa, G. Griemberg, and S. Llesuy Oxidative stress in blood of HIV infected patients Clin Chim Acta 255 1996 107 117
22. Z. Sheikh, R. Ahmad, N. Sheikh, and R. Ali Enhanced recognition of reactive oxygen species damage human serum albumin by circulating systemic lupus erythematosus autoantibodies Autoimmunity 40 2007 512 520
23. O.A. Bizzozero, G. De Jesus, K. Callahan, and A. Pastuszyn Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis J Neurosci Res 81 2005 687 695
24. S. Dasgupta, M. Jana, X. Liu, and K. Pahan Myelin basic protein-primed T cells induced nitric oxide synthase in microglial cells. Implications for multiple sclerosis J Biol Chem 277 2002 39327 39333
25. P. Guthikonda, J. Baker, and D.H. Mattson Interferon-beta-1-b (IFN-β) decreases induced nitric oxide (NO) production by a human astrocytoma cell line J Neuroimmunol 82 1998 133 139
26. A.N. Simão, M.A. Lozovoy, T.N. Simão, D. Venturini, D.S. Barbosa, and J.B. Dichi Immunological and biochemical parameters of patients with metabolic syndrome and the participation of oxidative and nitroactive stress Braz J Med Biol Res 44 2011 707 712
27. H.T. Besler, and S. Comoglu Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis Nutr Neurosci 6 2003 189 196
28. A. Ghiselli, M. Serafini, F. Natella, and C. Scaccini Total antioxidant capacity as a tool to assess redox status: critical view and experimental data Free Radic Biol Med 29 2000 1106 1114
29. A.N.C. Simão, J.B. Dichi, D.S. Barbosa, R. Cecchini, and I. Dichi Influence of uric acid and γ-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome Nutrition 24 2008 675 681
30. M.E. Van Meeteren, C.E. Teunissen, C.D. Dijkstra, and E.A. Van Tol Antioxidants and polyunsaturated fatty acids in multiple sclerosis Eur J Clin Nutr 59 2005 1347 1361
31. A. Greco, L. Minghetti, M. Puopolo, S. Cannoni, S. Romano, and C. Pozzilli Cerebrospinal fluid isoprostanes are not related to inflammatory activity in relapsing-remitting multiple sclerosis J Neurol Sci 224 2004 23 27
32. B. Bielekova, and R. Martin Development of biomarkers in multiple sclerosis Brain 127 2004 1463 1478